Copyright
©The Author(s) 2020.
World J Gastrointest Endosc. Feb 16, 2020; 12(2): 72-82
Published online Feb 16, 2020. doi: 10.4253/wjge.v12.i2.72
Published online Feb 16, 2020. doi: 10.4253/wjge.v12.i2.72
Patient characteristic | Number (n = 161) |
Mean age (yr) ± SD | 64.0 ± 14.7 |
Gender | |
Male | 112 (69.6) |
Female | 49 (30.4) |
Race | |
Chinese | 123 (76.4) |
Malay | 23 (14.3) |
Indian | 7 (4.3) |
Others | 8 (5.0) |
ASA score | |
1 | 27 (16.8) |
2 | 23 (14.3) |
3 | 111 (68.9) |
4 | 0 |
5 | 0 |
Blood thinning agent | |
Taking | 48 (29.8) |
Not taking | 113 (70.2) |
Bleeding dyscrasia | |
Present | 8 (5.0) |
Absent | 152 (94.4) |
Bleeding point | |
Single | 142 (88.2) |
> 1 | 19 (11.8) |
Admitted for bleeding initially | |
Yes | 118 (73.3) |
No | 43 (26.7) |
Treatment characteristic | Number (n = 161) |
Number of hemoclips used | |
0 | 87 (54.0) |
1 | 22 (13.7) |
2 | 48 (29.8) |
3 | 2 (1.2) |
4 | 1 (0.6) |
Volume of adrenaline used (mL) | |
0 | 9 (5.6) |
≤ 10 | 100 (62.1) |
> 10 | 52 (32.3) |
Heater probe use | |
Yes | 79 (49.1) |
No | 82 (50.1) |
Number of treatment modalities | |
≤ 2 | 127 (78.9) |
> 2 | 34 (21.1) |
Outcomes | Number (n = 161) |
Rebleeding | |
Yes | 42 (26.1) |
No | 119 (73.9) |
Need for repeat endoscopy | |
Yes | 47 (29.2) |
No | 114 (70.8) |
Need for surgery | |
Yes | 1 (0.6) |
No | 160 (99.4) |
Transfusion requirement | |
-Number of units of PRBC’s (Median/IQR) | 2/0-3 |
Length of hospital stay | |
-Number of days (Median/IQR) | 6/4-13 |
Death during same admission | |
Yes | 10 (6.2) |
No | 151 (93.8) |
30-d mortality | |
Yes | 0 |
No | 151 (93.8) |
- Citation: Yip BCH, Sayeed Sajjad H, Wang JX, Anastassiades CP. Endoscopic treatment modalities and outcomes in nonvariceal upper gastrointestinal bleeding. World J Gastrointest Endosc 2020; 12(2): 72-82
- URL: https://www.wjgnet.com/1948-5190/full/v12/i2/72.htm
- DOI: https://dx.doi.org/10.4253/wjge.v12.i2.72